Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: SIRIS PHARMACEUTICAL SERVICES LLC
Awarding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Funding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Period of performance: 2024-09-09 to 2025-09-10
Current total value of award: $440917.11
Description: TUBERCULOSIS (TB) CLINICAL TRIALS MANAGEMENT SUPPORT